2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2005020142v1 16/9/2615    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wada, T. Articles by Shankland, S. J. Search for Related Content PubMed PubMed Citation Articles by Wada, T. Articles by Shankland, S. J.

Dexamethasone Prevents Podocyte Apoptosis Induced by Puromycin Aminonucleoside: Role of p53 and Bcl-2–Related Family Proteins

Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington

Address correspondence to: Dr. Stuart J. Shankland, Division of Nephrology, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195. Phone: 206-543-2346; Fax: 206-685-8661; stuartjs{at}u.washington.edu

Received for publication February 5, 2005. Accepted for publication May 26, 2005.

Nephrotic-range proteinuria is due to glomerular diseases characterized by podocyte injury. Glucocorticoids are the standard of care for most forms of nephrotic syndrome. However, the precise mechanisms underlying the beneficial effects of glucocorticoids on podocytes, beyond its general immunosuppressive and anti-inflammatory effects, are still unknown. This study tested the hypothesis that the synthetic glucocorticoid dexamethasone directly reduces podocyte apoptosis. Growth-restricted immortalized mouse podocytes in culture were exposed to puromycin aminonucleoside (PA) to induce apoptosis. Our results showed that dexamethasone significantly reduced PA-induced apoptosis by 2.81-fold. Dexamethasone also rescued podocyte viability when exposed to PA. PA-induced apoptosis was associated with increased p53 expression, which was completely blocked by dexamethasone. Furthermore, the inhibition of p53 by the p53 inhibitor pifithrin- protected against PA-induced apoptosis. Dexamethasone also lowered the increase in the proapoptotic Bax, which was increased by PA, and increased expression of the antiapoptotic Bcl-xL protein. Moreover, the decrease in p53 by dexamethasone was associated with increased Bcl-xL levels. Podocyte apoptosis induced by PA was caspase-3 independent but was associated with the translocation of apoptosis-inducing factor (AIF) from the cytoplasm to nuclei. AIF translocation was inhibited by dexamethasone. These results show that PA-induced podocyte apoptosis is p53 dependent and associated with changes in Bcl-2–related proteins and AIF translocation. The protective effects of dexamethasone on PA-induced apoptosis were associated with decreasing p53, increasing Bcl-xL, and inhibition of AIF translocation. These novel findings provide new insights into the beneficial effects of corticosteroids on podocytes directly, independent of its immunosuppressive effects.

This article has been cited by other articles:

				J. Lorenzen, R. Shah, A. Biser, S. A. Staicu, T. Niranjan, A. M. Garcia, A. Gruenwald, D. B. Thomas, I. F. Shatat, K. Supe, et al. The Role of Osteopontin in the Development of Albuminuria J. Am. Soc. Nephrol., May 1, 2008; 19(5): 884 - 890. [Abstract] [Full Text] [PDF]

				H.-A. Shui, T.-H. Huang, S.-M. Ka, P.-H. Chen, Y.-F. Lin, and A. Chen Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis Nephrol. Dial. Transplant., January 1, 2008; 23(1): 176 - 185. [Abstract] [Full Text] [PDF]

				K. Brukamp, B. Jim, M. J. Moeller, and V. H. Haase Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1397 - F1407. [Abstract] [Full Text] [PDF]

				S. V. Griffin, J. P. Olivier, J. W. Pippin, J. M. Roberts, and S. J. Shankland Cyclin I Protects Podocytes from Apoptosis J. Biol. Chem., September 22, 2006; 281(38): 28048 - 28057. [Abstract] [Full Text] [PDF]

				M. P. Winn, N. Daskalakis, R. F. Spurney, and J. P. Middleton Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome: Does It Have Clinical Implications? J. Am. Soc. Nephrol., February 1, 2006; 17(2): 378 - 387. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673